World Arthritis Day 12 Oct 2021: Don't Delay, Healthy Every Day
World Arthritis Day is observed on October 12, every year since 1996. World Arthritis Day is observed to raise awareness about Arthritis around the world. The most common form of arthritis is osteoarthritis. Other forms include gout, rheumatoid arthritis (RA), and lupus. RA is a systemic inflammatory disease that is characterized by a progressive and disabling course. The prevalence of RA is 0.5-1%, with a woman to man ratio of 3:1. It is 4 to 5 times higher in women under 50 years, but after 60 years the ratio becomes approximately 2 to 1. People with rheumatoid arthritis often have an elevated erythrocyte sedimentation rate (ESR, also known as sed rate) or C-reactive protein (CRP) level, which may indicate the presence of an inflammatory process in the body. Other common blood tests look for rheumatoid factor (FR) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. Systemic manifestations and complications of RA - including pulmonary, cardiovascular, neurological, and musculoskeletal involvements; glucocorticoid (GC)-induced osteoporosis (GIOP); and infection - which have significant impacts on the disease outcomes, occur in approximately 40% of patients. With the increasing recognition of RA and development of novel treatment strategies, early diagnosis and prompt treatment may result in some patients achieving remission status or low disease activity. RA patients with systemic manifestations or complications should be treated and monitored more aggressively to reduce their risk of mortality.
YHLO provides one-stop RA screening for early diagnosis and timely treatment to prevent future problems.
Reference
[1] Intriago M, Maldonado G, Cárdenas J, et al. Clinical characteristics in patients with rheumatoid arthritis: differences between genders[J]. The Scientific World Journal, 2019, 2019.
[2] Kim J W, Suh C H. Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis[J]. 2020.
#Arthritis #RheumatoidArthritis #Diagnostics #Serology #ESR #CRP #RF #Anti-CCP
Attachments:
MORE NEWS
n November 18, 2025, YHLO’s 2025 Global Core Distributors Conference was successfully held in Düsseldorf, Germany. Under the theme “Academia-Driven, Shared Value,” the meeting brought together representatives from more than 30 core distributors worldwide. YHLO’s founder, Mr. Deming Hu, and Chairman, Mr. Kunhui Hu, led the company’s executive team to attend and discuss strategic development with partners.
2025-11-20
YHLO Secures Approval for the World’s First sCD146 CLIA Assay
YHLO has obtained approval from the Guangdong Medical Products Administration for its soluble CD146 (sCD146) CLIA assay, marking a major milestone in central nervous system (CNS) disease diagnostics. YHLO is now the first company worldwide to offer an sCD146 test for cerebrospinal fluid, bringing its total CLIA assay portfolio in China to 173.
2025-11-18
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
